Similar Items: Engineering of African horse sickness virus vaccine candidates by targeting the VP4 protein responsible for capping and methylation of viral mRNA
- The Development of an African Horse Sickness Virus VP7 Quasi-Crystal Vaccine Candidate in N. benthamiana
- Characterization of VP4, a minor core protein of African horse sickness virus with putative capping enzyme activity
- The development of vaccine delivery systems based on presenting peptides on the surface of core protein VP7 of African horse sickness virus
- Multi-epitope mRNA vaccine and protein vaccine protect mice against
- Comparing COVID-19 vaccine effectiveness in Türkiye: heterologous, inactivated, and mRNA vaccines
- Investigating the production of a particulate plant-produced vaccine candidate against African horse sickness
Author: Theron, Jacques
- Characterization of genetic elements up-regulated in Pseudomonas aeruginosa PAO biofilms and transcriptional activity of the flagellar hook protein gene, flgE, during biofilm development
- Evaluation of thermally regulated promoter systems for use in Escherichia coli and Bacillus subtilis
- Expression of the botulinum neurotoxin serotype D binding domain in Brevibacillus brevis and its evaluation as a candidate vaccine antigen in mice
- Proteomic analysis of the biofilm and biofilm-associated phenotypes of Pseudomonas aeruginosa cultured in batch
- Identification of viral proteins and cellular pathways involved in the induction of apoptosis of African horse sickness virus-infected mammalian cells
- Importance of an arginine-glycine-aspartic acid (RGD) motif in the VP7 protein of African horse sickness virus to mediate insect cell binding